Finance

Beta
Lists
DMAC:NASDAQ
DiaMedica Therapeutics Inc
$5.85
+2.09%
(+0.12) 1D
$5.85
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAC...
Open
$5.76
High
$5.87
Low
$5.61
Mkt. cap
315.22M
Avg. vol.
172.34K
Volume
226.74K
52-wk high
$10.42
52-wk low
$3.48
EPS
-$0.71
Beta
0.97
Shares outstanding
53.88M
No. of employees
35
Open
$5.76
High
$5.87
Low
$5.61
Mkt. cap
315.22M
Avg. vol.
172.34K
Volume
226.74K
52-wk high
$10.42
52-wk low
$3.48
EPS
-$0.71
Beta
0.97
Shares outstanding
53.88M
No. of employees
35
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to DMAC in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DMAC in the last 3 months.
Highest
Current $5.85
$14.00 (+139.32%)
Average
$13.00 (+122.22%)
Lowest
$12.00 (+105.13%)
News stories
From sources across the web
About DiaMedica Therapeutics Inc
CEO-
Employees35
Founded2000
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitediamedica.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.82M
6.44M
6.70M
7.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.18M
2.60M
2.51M
2.50M
Operating expense
8.01M
9.03M
9.21M
10.48M
Total operating expenses
8.01M
9.03M
9.21M
10.48M
Operating income
-8.01M
-9.03M
-9.21M
-10.48M
Other non operating income
314.00K
419.00K
-1.18M
-
EBT including unusual items
-7.69M
-8.61M
-8.73M
-10.04M
EBT excluding unusual items
-7.69M
-8.61M
-8.73M
-10.04M
Income tax expense
6.00K
6.00K
10.00K
7.00K
Effective tax rate
-0.08%
-0.07%
-0.11%
-0.07%
Other operating expenses
-
-
-
-
Net income
-7.70M
-8.62M
-8.74M
-10.04M
Net profit margin
-
-
-
-
Earnings per share
-0.18
-0.17
-0.17
-0.19
Interest and investment income
-
-
1.66M
447.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
1.66M
447.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.00M
-9.02M
-9.20M
-10.47M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer